About Myocyte-specific enhancer factor 2C
Myocyte-specific enhancer factor 2C (MEF2C) is a protein
from Homo sapiens identified by UniProt accession
Q06413, 473 residues long.
MolForge cross-references it against 0 known binders and
436 disease associations.
Target properties
| Protein name | Myocyte-specific enhancer factor 2C |
| UniProt accession | Q06413 |
| Gene | MEF2C |
| Organism | Homo sapiens |
| Length | 473 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (436)
Diseases linked to this target (Open Targets).
- 5q14.3 microdeletion syndrome · score 0.57
- autism spectrum disorder · score 0.56
- genetic disorder · score 0.53
- mean corpuscular volume · score 0.52
- platelet count · score 0.52
- erythrocyte count · score 0.52
- self reported educational attainment · score 0.51
- mean platelet volume · score 0.51
- mean corpuscular hemoglobin · score 0.50
- mean corpuscular hemoglobin concentration · score 0.49
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q06413-F1 | alphafold | PREDICTED | 55.65 | — |
Amino-acid sequence (473 residues)
MGRKKIQITR IMDERNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNS TNKLFQYAST DMDKVLLKYT EYNEPHESRT NSDIVETLRK KGLNGCDSPD PDADDSVGHS PESEDKYRKI NEDIDLMISR QRLCAVPPPN FEMPVSIPVS SHNSLVYSNP VSSLGNPNLL PLAHPSLQRN SMSPGVTHRP PSAGNTGGLM GGDLTSGAGT SAGNGYGNPR NSPGLLVSPG NLNKNMQAKS PPPMNLGMNN RKPDLRVLIP PGSKNTMPSV SEDVDLLLNQ RINNSQSAQS LATPVVSVAT PTLPGQGMGG YPSAISTTYG TEYSLSSADL SSLSGFNTAS ALHLGSVTGW QQQHLHNMPP SALSQLGACT STHLSQSSNL SLPSTQSLNI KSEPVSPPRD RTTTPSRYPQ HTRHEAGRSP VDSLSSCSSS YDGSDREDHR NEFHSPIGLT RPSPDERESP SVKRMRLSEG WAT
Explore Myocyte-specific enhancer factor 2C with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets